ADC Therapeutics SA

ADCT

Exchange: NYSE
Industry: Pharmaceutical Preparations
SEC CIK: 0001771910

SEC filings (opens in a new tab)

No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding ADC Therapeutics SA changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of ADCT: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	118	1	113	−4
Shares	83.5M	10.4K	80.7M	−2.76M (−3.3%)
Value	$312.9M	$38.9K	$86.3M	−$226.5M (−72.4%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held ADC Therapeutics SA at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to ADCT in Q2 2026
Institution	Shares	Value	% of portfolio
Opaleye Management Inc.	700,000	$749.0K	0.07%
Jacobs Levy Equity Management, Inc	141,344	$151.2K	0.00%
Colony Group, LLC	111,801	$119.6K	0.00%
Quadrature Capital Ltd	105,690	$113.1K	0.00%
Revolve Wealth Partners, LLC	100,000	$107.0K	0.01%
Gsa Capital Partners LLP	54,695	$59.0K	0.00%
Verition Fund Management LLC	40,330	$43.2K	0.00%
Brevan Howard Capital Management LP	36,885	$39.5K	0.00%
State of Alaska, Department of Revenue	30,000	$32.0K	0.00%
Axq Capital, LP	27,407	$29.3K	0.00%
Cerity Partners LLC	27,144	$29.0K	0.00%
Neuberger Berman Group LLC	20,661	$22.1K	0.00%
Ground Swell Capital, LLC	20,408	$21.8K	0.02%
Centiva Capital, LP	17,683	$18.9K	0.00%
JustInvest LLC	17,007	$18.2K	0.00%
Engineers Gate Manager LP	13,493	$14.4K	0.00%
Pallas Capital Advisors LLC	12,601	$13.5K	0.00%
Meridian Wealth Management, LLC	12,577	$13.5K	0.00%
Perigon Wealth Management, LLC	10,656	$11.4K	0.00%
Simplex Trading, LLC	8,197	$8.77K	0.00%
SRS Capital Advisors, Inc.	1,104	$1.18K	0.00%
SBI Securities Co., Ltd.	222	$238	0.00%
Farther Finance Advisors, LLC	197	$211	0.00%
Clearstead Advisors, LLC	36	$39	0.00%
SJS Investment Consulting Inc.	32	$35	0.00%
IFG Advisory, LLC	15	$16	0.00%

Sold out (30)

Institutions that held ADC Therapeutics SA at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of ADCT in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Eventide Asset Management, LLC	5,701,655	$21.4M
OrbiMed Advisors LLC	1,318,026	$4.94M
Voleon Capital Management LP	513,831	$1.93M
Renaissance Technologies LLC	299,278	$1.12M
Lazard Asset Management LLC	262,595	$984.7K
Squarepoint Ops LLC	156,126	$585.5K
Kingswood Wealth Advisors, LLC	105,107	$394.2K
Cantor Fitzgerald, L. P.	100,000	$375.0K
Balyasny Asset Management LLC	77,947	$292.3K
Walleye Capital LLC	77,390	$290.2K
Susquehanna International Group, LLP	76,268	$286.0K
MetLife Investment Management	53,690	$201.3K
Marshall Wace, LLP	45,479	$170.5K
Dynamic Technology Lab Private Ltd	43,970	$164.9K
Jump Financial, LLC	32,230	$120.9K
Vanguard Global Advisers, LLC	31,593	$118.5K
Manufacturers Life Insurance Company, The	25,826	$96.8K
Graham Capital Management, L.P.	22,442	$84.2K
ExodusPoint Capital Management, LP	19,280	$72.3K
Voya Investment Management LLC	17,395	$65.2K
Aquatic Capital Management LLC	16,718	$62.7K
Quantinno Capital Management LP	14,719	$55.2K
Ethic Inc.	11,755	$44.1K
HSBC Holdings PLC	10,577	$40.0K
C M Bidwell & Associates Ltd	1,119	$4.20K
Quadrant Capital Group LLC	173	$649
Root Financial Partners, LLC	89	$334
MAI Capital Management	29	$109
True Wealth Design, LLC	21	$79
Twin Peaks Wealth Advisors, LLC	2	$8

Not filed for Q2 2026 yet (1)

Institutions that held ADC Therapeutics SA at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ADCT in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
CWM, LLC	10,362	$38.9K